The relationship between blood lactate and survival following the use of adrenaline in the treatment of septic shock

Anaesthesia and Intensive Care

Volumn 39, Issue 3, 2011, Pages 449-455

  Omar, S ^a   Burchard, A T ^a,b   Lundgren, A C ^a   Mathivha, L R ^a   Dulhunty, J M ^a,c  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b Department of Anaesthesia ^*

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Adrenaline; Blood lactate; Septic shock; Survival

Indexed keywords

ADRENALIN; LACTIC ACID;

ADULT; AGED; APACHE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG USE; FEMALE; HUMAN; INTENSIVE CARE UNIT; LACTATE BLOOD LEVEL; MALE; MEAN ARTERIAL PRESSURE; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; SEPTIC SHOCK; SURVIVAL;

EID: 79957886419     PISSN: 0310057X     EISSN: 14480271     Source Type: Journal    
DOI: 10.1177/0310057x1103900316     Document Type: Article

References (27)

1. Huckabee WE. Abnormal resting blood lactate. I. The significance of hyperlactatemia in hospitalized patients. Am J Med 1961; 30:840-848.
2. Weil MH, Afifi AA. Experimental and clinical studies on lactate and pyruvate as indicators of the severity of acute circulatory failure (shock). Circulation 1970; 41:989-1001.
3. Vitek V, Cowley RA. Blood lactate in the prognosis of various forms of shock. Ann Surg 1971; 173:308-313.
4. Moomey CB Jr, Melton SM, Croce MA, Fabian TC, Proctor KG. Prognostic value of blood lactate, base deficit, and oxygen-derived variables in an LD50 model of penetrating trauma. Crit Care Med 1999; 27:154-161. (Pubitemid 29052831)
5. Peretz DI, Scott HM, Duff J, Dossetor JB, MacLean LD, McGregor M. The significance of lacticacidemia in the shock syndrome. Ann N Y Acad Sci 1965; 119:1133-1141.
6. Cowan BN, Burns HJ, Boyle P, Ledingham IM. The relative prognostic value of lactate and haemodynamic measurements in early shock. Anaesthesia 1984; 39:750-755. (Pubitemid 15076606)
7. + ATPase activity and raised lactate concentrations in septic shock: a prospective study. Lancet 2005; 365:871-875.
8. Leverve XM, Mustafa I. Lactate: a key metabolite in the intercellular metabolic interplay. Crit Care 2002; 6:284-285. (Pubitemid 34863690)
9. Asfar P, Hauser B, Radermacher P, Matejovic M. Catecholamines and vasopressin during critical illness. Crit Care Clin 2006; 22:131-149. (Pubitemid 43037114)
10. Bassi G, Radermacher P, Calzia E. Catecholamines and vasopressin during critical illness. Endocrinol Metab Clin North Am 2006; 35:839-857. (Pubitemid 44802968)
11. Barth E, Albuszies G, Baumgart K, Matejovic M, Wachter U, Vogt J et al. Glucose metabolism and catecholamines. Crit Care Med 2007; 35:S508-518.
12. Myburgh JA, Higgins A, Jovanovska A, Lipman J, Ramakrishnan N, Santamaria J. A comparison of epinephrine and norepinephrine in critically ill patients. Intensive Care Med 2008; 34:2226-2234.
13. Annane D, Vignon P, Renault A, Bollaert P-E, Charpentier C, Martin C et al. Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial. Lancet 2007; 370:676-684. (Pubitemid 47299251)
14. Matejovic M, Radermacher P, Fontaine E. Lactate in shock: a high-octane fuel for the heart? Intensive Care Med 2007;33:406-408.
15. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101:1644-1655.
16. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13:818-829.
17. Gullo A, Bianco N, Berlot G. Management of severe sepsis and septic shock: challenges and recommendations. Crit Care Clin 2006; 22:489-501. (Pubitemid 44163092)
18. Friedman G, Silva E, Vincent JL. Has the mortality of septic shock changed with time. Crit Care Med 1998; 26:2078-2086. (Pubitemid 29016694)
19. Levy B, Mansart A, Bollaert P-E, Franck P, Mallie J-P. Effects of epinephrine and norepinephrine on hemodynamics, oxidative metabolism, and organ energetics in endotoxemic rats. Intensive Care Med 2003; 29:292-300. (Pubitemid 36384420)
20. Sair M, Etherington PJ, Peter Winlove C, Evans TW. Tissue oxygenation and perfusion in patients with systemic sepsis. Crit Care Med 2001; 29:1343-1349. (Pubitemid 32641795)
21. Mikkelsen ME, Miltiades AN, Gaieski DF, Goyal M, Fuchs BD, Shah CV et al. Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock. Crit Care Med 2009; 37:1670-1677.
22. Gladden LB. Lactate metabolism: a new paradigm for the third millennium. J Physiol 2004; 558:5-30. (Pubitemid 39077388)
23. Levy B, Mansart A, Montemont C, Gibot S, Mallie J-P, Regnault V et al. Myocardial lactate deprivation is associated with decreased cardiovascular performance, decreased myocardial energetics, and early death in endotoxic shock. Intensive Care Med 2007; 33:495-502. (Pubitemid 46333851)
24. Seely AJ, Christou NV. Multiple organ dysfunction syndrome: exploring the paradigm of complex nonlinear systems. Crit Care Med 2000; 28:2193-2200. (Pubitemid 30604415)
25. Buchman TG. Nonlinear dynamics, complex systems, and the pathobiology of critical illness. Curr Opin Crit Care 2004;10:378-382. (Pubitemid 39313508)
26. Godin PJ, Buchman TG. Uncoupling of biological oscillators: a complementary hypothesis concerning the pathogenesis of multiple organ dysfunction syndrome. Crit Care Med 1996;24:1107-1116. (Pubitemid 26249359)
27. Nguyen HB, Rivers EP, Knoblich BP, Jacobsen G, Muzzin A, Ressler JA et al. Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit Care Med 2004; 32:1637-1642. (Pubitemid 39050511)